Literature DB >> 7715705

Activation of microglial cells by beta-amyloid protein and interferon-gamma.

L Meda1, M A Cassatella, G I Szendrei, L Otvos, P Baron, M Villalba, D Ferrari, F Rossi.   

Abstract

Alzheimer's disease is the most common cause of progressive intellectual failure. The lesions that develop, called senile plaques, are extracellular deposits principally composed of insoluble aggregates of beta-amyloid protein (A beta), infiltrated by reactive microglia and astrocytes. Although A beta, and a portion of it, the fragment 25-35 (A beta (25-35)), have been shown to exert a direct toxic effect on neurons, the role of microglia in such neuronal injury remains unclear. Here we report a synergistic effect between A beta and interferon-gamma (IFN-gamma) in triggering the production of reactive nitrogen intermediates and tumour-necrosis factor-alpha (TNF-alpha) from microglia. Furthermore, using co-culture experiments, we show that activation of microglia with IFN-gamma and A beta leads to neuronal cell injury in vitro. These findings suggest that A beta and IFN-gamma activate microglia to produce reactive nitrogen intermediates and TNF-alpha, and this may have a role in the pathogenesis of neuronal degeneration observed in ageing and Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7715705     DOI: 10.1038/374647a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  317 in total

Review 1.  Microglia and the immune pathology of Alzheimer disease.

Authors:  D Giulian
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

2.  Association of microglia with amyloid plaques in brains of APP23 transgenic mice.

Authors:  M Stalder; A Phinney; A Probst; B Sommer; M Staufenbiel; M Jucker
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

3.  Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis.

Authors:  B Kaltschmidt; M Uherek; H Wellmann; B Volk; C Kaltschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

4.  A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation.

Authors:  Maria E Bamberger; Meera E Harris; Douglas R McDonald; Jens Husemann; Gary E Landreth
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

5.  Hematopoietic CC-chemokine receptor 2 (CCR2) competent cells are protective for the cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease.

Authors:  Gaëlle Naert; Serge Rivest
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

6.  CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase.

Authors:  J Tan; T Town; T Mori; Y Wu; M Saxe; F Crawford; M Mullan
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

7.  Identification of upregulated genes in scrapie-infected brain tissue.

Authors:  C Riemer; I Queck; D Simon; R Kurth; M Baier
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

8.  Matairesinol Suppresses Neuroinflammation and Migration Associated with Src and ERK1/2-NF-κB Pathway in Activating BV2 Microglia.

Authors:  Peng Xu; Meng-Wei Huang; Chen-Xi Xiao; Fen Long; Ying Wang; Si-Yu Liu; Wan-Wan Jia; Wei-Jun Wu; Di Yang; Jin-Feng Hu; Xin-Hua Liu; Yi-Zhun Zhu
Journal:  Neurochem Res       Date:  2017-05-17       Impact factor: 3.996

9.  Lipopolysaccharide-induced down-regulation of Ca2+ release-activated Ca2+ currents (I CRAC) but not Ca2+-activated TRPM4-like currents (I CAN) in cultured mouse microglial cells.

Authors:  Andreas Beck; Reinhold Penner; Andrea Fleig
Journal:  J Physiol       Date:  2007-11-08       Impact factor: 5.182

10.  Microglial activation in the hippocampus of hypercholesterolemic rabbits occurs independent of increased amyloid production.

Authors:  Qing-Shan Xue; D Larry Sparks; Wolfgang J Streit
Journal:  J Neuroinflammation       Date:  2007-08-24       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.